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Sex ratio of the mutation frequencies in
haemophilia A: coagulation assays and RFLP
analysis
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Abstract
Coagulation and RFLP data frorn 41 families
with an isolated haemophilia A patient were
used to estitnate the sex ratio of mutation
frequencies (ν/μ). Based on the results of co-
agulation assays in all the female relatives
investigated, ν/μ was estimated to be 12-1 by
the maximum likelihood method (95% confid-
ence interval 3-8 to 62-5). In order to avoid the
possible influence of germline mosaicism, an
additional analysis was performed in which
only the results in the mothers and grand-
mothers of an isolated patient were included.
The ν/μ ratio was then estimated to be 5-2 (95%
confidence interval Γ8 to 15-1).
Because an estimate of ν/μ based on all
available RFLP data can easily be biased in
favour of males, we set up a tnodel in which
only Information on the grandparental de-
rivation of the patient's X chromosome was
used, irrespective of the generation in which
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the mutation actually occurred. In this way ν/μ
was estimated to be minimally 4.
The probability of carriership for mothers
of an isolated haemophilia A patient amounts
to 86% with a sex ratio of 5-2. Although this
would imply that 14% of the mothers are not
carriers of the disease in the classical sense,
they may be mosaic for the mutation and,
therefore, also at risk of transmitting the mu-
tation more than once.
One-third of patients with haemophilia have no
affected male relatives.12 Therefore, the question of
which of the female relatives of diese isolated
patients are at risk for being a carrier is of major
importance in genetic counselling for haemophilia.
The probability of carriership for female relatives
of isolated patients is determined by the origin of the
mutation in the family and depends on the ratio of
the mutation frequency in males (v) and females (μ).
If mutations occur predominantly in males, a high
Proportion of the mothers of an isolated patient will
be carriers of the disease. On the other hand, the
more often mutations occur in females, the more
isolated patients will be sons of non-carrier mothers
and be so-called 'true sporadic patients'.
The sex ratio of the mutation frequencies (ν/μ) for
haemophilia has been estimated by different meth-
ods. In 1935, Haldane3 showed that for X linked
recessive diseases ν/μ can be derived from the pro-
portion of sporadic patients of all patients (x) by the
equation χ = μ/(2μ-t-v), provided that genetic equi-
librium is present. This proportion χ is expected to
be 1/3, when ν/μ equals 1. The proportion of spor-
adic cases is expected to be lower than 1/3 when
mutations occur more frequently in males than in
females, and also when affected males have signific-
ant reproductive fitness. Theoretically, the fitness of
carrier females may be of influence äs well. A modi-
fication of Haldane's equation, which accounts for
all these factors, was derived by Holloway and
Smith.4 The proportion of sporadic patients (x) can
be determined either by segregation analysis or by
carrier detection tests in mothers of an affected male.
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In addition to genetic equilibrium, Haldane's
method requires complete or unbiased ascertain-
ment of affected males or mothers of an affected
male. If ascertainment is incomplete, families with
more than one affected male are more likely to be
included, which leads to an underestimation of the
Proportion of sporadic patients and, consequently,
to an overestimation of ν/μ. In order to eliminate
ascertainment bias, Davie and Emery5 and, later,
Winter6 developed a method by which the propor-
tion of sporadic patients (x) is estimated using only
data from families with an isolated patient.
In haemophilia, genetic equilibrium is highly
unlikely. Life expectancy of patients with haemo-
philia has markedly increased over the years,78 and
so has their reproductive fitness.9 Therefore, the
fitness of the patients who have contributed to the
population under study is difficult to assess, and the
assumption of a steady state is unwarranted.
Recently, we have argued that, under certain
conditions, limitation of pedigree analysis to families
with an (initially) isolated haemophilia patient
allows an estimate of ν/μ independent of the fitness
of affected males and of the existence of genetic
equilibrium.10
During the last five years, developments in DNA
technology have provided new means to determine
the origin of mutations. Restriction fragment length
polymorphisms (RFLPs) within or closely linked to
the factor VIII gene can be used to trace the inherit-
ance of the patient's X chromosome. The generation
in which the mutation has occurred may thus be
defined, äs well äs the male or female origin of the
mutation. Müller and Grimm" proposed a method
to estimate ν/μ from the proportion of patients of all
patients who inherited their maternal grandfather's
X chromosome. As in the method of Haldane, this
estimate is very sensitive to ascertainment bias, in
such a way that overrepresentation of familial cases
may cause an underestimate of ν/μ.1213 Α method
theoretically free of ascertainment bias was de-
veloped by Karel et al.lt This method, however,
requires so many pedigrees of a specific, infre-
quently occurring type that it is only feasible
through large scale collaboration over a long period.
We have obtained an estimate of ν/μ from the
results of coagulation assays and RFLP analysis in
41 families with an isolated haemophilia A patient.
For the Interpretation of the coagulation assays, we
have developed a method that resembles the method
described by Winter.6 From the RFLP data,
Information on the grandparental origin of the
patient's X chromosome was used to estimate ν/μ.
For this purpose the model of Müller and Grimm"
was modified for application in families with an
isolated haemophilia A patient.
Subjects and methods
SUBJECTS
We investigated subjects from 41 families with an
isolated haemophilia A patient. All the families were
referred to our centre during the years 1984 to 1989
for genetic counselling of the female relatives.
Extensive family histories, which covered informa-
tion about the great grandfathers, grandfathers,
brothers, cousins, nephews, uncles, and great uncles
of the patient, were taken to exclude previously
affected males in the pedigree. Since the occurrence
of mild haemophilia cannot be reliably assessed in
this way, we restricted the analysis to families in
which the patient had a moderately severe (n = 6) or
a severe (n = 35) form of haemophilia A, that is, less
than 5% clotting factor VIII activity.
COAGULATION ASSAYS
Coagulation assays were performed in all the
mothers of the isolated patients, in 19 of the 41
maternal grandmothers, and in 66 other female
relatives, which included sisters, aunts, cousins, and
nieces.
For this purpose, 9 ml of blood was obtained and
added to l ml of sodium citrate (3-2%). Immediately
after collection, the citrated blood was spun at high
speed and the platelet-poor plasma was dispensed in
capped disposable plastic tubes. The plasma was
then deep frozen and stored at — 70°C. The tubes
were thawed immediately before testing and assayed
within two months of blood collection. We took care
that the sampling, processing, and storage of blood
was accomplished by a minimum number of
experienced persons and in a consistent way on all
occasions.
Factor VIII coagulant activity (VIII:c) was
measured by a one stage clotting assay,15 and von
Willebrand factor antigen (vWf:Ag) by Laurell
immunoelectrophoresis.16 Bleeding time (method of
Ivy) and haematocrit were checked, and blood
groups were determined for statistical purposes.
RFLP ANALYSIS
Restriction fragment length polymorphism (RFLP)
analysis was carried out in all of the 41 families. In
13 families both maternal grandparents could be
investigated, in eight families only the maternal
grandmother, and in the remaining 20 families
neither of them was available for DNA analysis.
However, in some families the RFLP haplotype of
the X chromosomes of the grandparents could be
deduced from those of their children.
We used two intragenic RFLPs, F8a/ßc/P7 and
F8b/XfcaI,18 and two extragenic RFLPs, Stl4/
674 Bröcker- Vriends, Rosendaal, van Houwelingen, Bakker, van Ommen, van de Kamp, Briet
Taql19 and DX13/ß^/II.20 The recombination fre-
quency between the extragenic markers and the
clotting factor VIII gene is approximately 5%.21
The methods of DNA analysis used in our centre
have been described previously for each of the
aforementioned RFLPs.2223
STATISTICAL METHODS
For each woman, the likelihood ratio of carrier/non-
carrier based on the results of coagulation assays
(LR-VIII) was calculated by discriminant analysis
with correction for age and blood group.24 LR-VIIIs
greater than 100:1 or smaller than 1:100 were
trimmed to 100:1 or 1:100, respectively, to avoid a
disproportionate influence of outlying values in
further statistical pröcedures. The LR-VIIIs for the
females were combined with the pedigree Informa-
tion, more specifically the number and genetic Status
of the males, to estimate the sex ratio of mutation
frequencies by the maximum likelihood method.
The results of RFLP analysis were evaluated separ-
ately. The proportion of mothers of an isolated
patient who are expected to be carriers of the disease
was calculated according to Rosendaal et a/.10
Estimation of the sex ratio of mutation frequencies by
pedigree analysis and coagulation assays
We have derived an expression for the likelihood of
the outcome of carrier detection tests on women in a
specific pedigree, conditional on the number and
genetic Status of the male relatives. In this expres-
sion the likelihood is a function of two parameters
designated δ, and 52. The parameter δ, equals Ω/μ,
where Ω is the probability of carriership for the
woman in the pedigree, for whom there is no reliable
previous Information, the progenitor. The para-
meter 52 equals (μ + ν)/μ. The derivation of the
expression is given in the appendix.
From the likelihood for the outcome of carrier
detection tests in all the pedigrees investigated,
which is the product of the individual likelihoods
(see appendix), the parameters δ, and δ2 can be
estimated by the maximum likelihood method. Con-
fidence intervals can be obtained by calculation of
the Standard error by the second derivative of the log
likelihood function or by taking all values of the
unknown parameter for which log likelihood is equal
to or greater than the maximum log likelihood minus
1-92 (1-92 = 0-5 x 3-84; 3-84 is the 95th centile of the
χ
2
 distribution). Because in this study the log likeli-
hoods for ν/μ (ν/μ = δ2— 1) appeared to be asymmet-
rical about their mode, we have chosen the last
approach to obtain the confidence interval for ν/μ.
The log likelihood curves for ν/μ were constructed
by maximisation of the original log likelihood with
respect to δ, (at a fixed value of ν/μ).
In this study, it was impossible to estimate δ, with
a high degree of pre'cision. This is owing to lack of
substantial information, that is, carrier detection
tests, in the more remote generations. We found,
however, that the log likelihood curve for ν/μ was
not notably influenced by entering different values
for δ,.
Estimation of the sex ratio of mutation frequencies by
RFLP analysis
From the results of RFLP analysis, the grandparen-
tal derivation of the X chromosome of an affected
male can be deduced, irrespective of the generation
in which the mutation occurred. We have evaluated
the significance of the grandparental derivation of an
isolated patient's X chromosome for the sex ratio of
mutation frequencies (ν/μ).
The grandpaternal X chromosome (GP-X) may
appear in an affected grandson because of a mutation
during spermatogenesis resulting in a carrier
daughter, who subsequently transmitted this X
chromosome to her son (v/2) or because of a muta-
tion in the patient's mother (μ). The grandmaternal
X chromosome (GM-X) may appear in an affected
grandson because of carriership of the maternal
grandmother (1/4Ω), by a new mutation in the
grandmother resulting in a carrier daughter who
subsequently transmitted the X chromosome to her
son (μ/2), or because of a mutation in the patient's
mother (μ). If we consider only families with no
affected male relatives in the grandparental or more
distant generations, the prior probability of carrier-
ship for the grandmother (Ω) approximates
2μ + 2ν.'° The conditional probability for the
patient's X chromosome having been inherited
either from the grandfather or the grandmother is
then
GP-X: ν/2 + μ
GM-X: (2μ + 2v)/4 + μ/2 + μ
and the ratio for the grandparental derivation
becomes
GP-X/GM-X = (v + 2μ)/(ν + 4μ) = (k + 2)/(k + 4)
wherein ν/μ is denoted by k. It can be seen that for
this type of family, the ratio GP-X/GM-X is never
expected to exceed l, even if mutations occurred
exclusively in males.
We restricted our investigation to families with an
isolated patient which means that we excluded those
in which the grandmothers had more than one
descendant with haemophilia. The prior probability
of carriership for the grandmothers in our study
Population is thus a fraction (t) of the prior probab-
ility for all the grandmothers with no previous
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family history of haemophilia. Accordingly, the ratio
GP-X/GM-X in families with an isolated patient
equals
GP-X/GM-X = (k + 2)/t(k +1) + 3
and depends not only on ν/μ, but also on the fraction
of carrier grandmothers included in the analysis. If
none of the carrier grandmothers is included (t = 0),
the ratio GP-X/GM-X is expected to equal l in case
μ = v and to exceed l in case v > μ. The more carrier
grandmothers included (t > 0), the less likely that a
higher mutation frequency in males will result in
predominant inheritance of the grandpaternal X
chromosome (fig 1). In other words, whatever the
value of t, when the patient's X chromosome is
found to be derived more often from the grandfather
than from the grandmother, this Unding always
indicates a higher mutation frequency in males. A
minimum value of ν/μ can be derived from the ratio
GP-X/GM-X, assuming t = 0.
Results
ESTIMATION OF THE SEX RATIO OF MUTATION
FREQUENCIES BY PEDIGREE ANALYSIS AND
COAGULATION ASSAYS
First, a maximum likelihood estimate of ν/μ was
obtained by use of the Information from the pedi-
grees and the LR-VIII for all the female relatives
investigated. The mutation ratio (ν/μ) was estimated
ο
χ
14-
12-
10-
o8
6-
4-
2-
t=0
t=1/2
t=1
1/40 1/30 1/20 1/10 1 10 20 30 40
K
Figure l Theoretical relationship betvieen the
grandparental derivation of a patient's X chromosome and
v/μ. The relationship applies to families in vihich no male
relatives are affected in the grandparental or more remote
generations of the index case and is expressed by the
equation GP-X/GM-X='(k + 2)/t(k +1)+3, where 't' is
the fraction of carrier grandmothers included in the study.
GP-X=grandpaternally derived X chromosome.
GM-X=grandmaternally derived X chromosome. £ = ν/μ.
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Figure 2 Log likelihood curve for the sex ratio of mutation
frequencies (v/μ) based on the results of coagulation assays
in all the female relatives of isolated haemophilia A patients
investigated (n = 41). The horizontal line corresponds to the
maximum log likelihood minus 1-92 and has been used to
compute the 95% conßdence interval of ν/μ (see Methods).
to be 12-1 with a 95% confidence interval of 3-8 to
62-5 (fig 2).
In four of the families the patient's mother was
more likely to be a carrier than a non-carrier, not on
the basis of her own factor VIII levels but on the
basis of those of her daughter. In these cases the
daughters conferred on their mother an LR which
almost equalled that of a second son with haemo-
philia (table 1). Although normal factor VIII values
may have been found in the mother because of
preferential lyonisation of the mutated X chromo-
some, germline mosaicism may be an explanation äs
well.
In order to avoid the possible influence of this
phenomenon, we performed an additional analysis,
in which only the results of coagulation assays in
mothers and grandmothers of the isolated patients
were included. The ratio ν/μ was then estimated to
Table l Contradictory results of coagulation assays
betvieen the mother of an isolated patient and her daughter.
Pedigree and subject LR-VIII«
A19f
Mother
Daughter
A29
Mother
Daughter
A30
Mother
Daughter
A34
Mother
Daughter
0-08
>100
0-03
>100
0-3
>100
0-02
>100
* Likelihood ratio carrier/non-carrier based on the results of factor
VIII and von Willebrand factor assays according to Green et al";
for further statistical procedures values above 100:1 wcre trimmed
to 100:1.
t Somatic and germline mosaicism for a partial deletion in the
FVIII gene was found in the mother.25
. ··.·:'v! V.
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Figure 3 Log likelihood curvefor the sex ratio ofmutationfrequencies (ν/μ) based an the results of coagulation assays
in the mothers and grandmothers of isolated haemophilia A
patients (n = 41). The horizontal line corresponds to the
maximum log likelihood minus 1-92 and hos been used to
compute the 95% confidence interval of ν/μ (see Methods).
be 5-2 with a 95% confidence interval of 1-8 to 15-1
(fig 3).
ESTIMATION OF THE SEX RATIO OF MUTATION
FREQUENCIES BY RFLP ANALYSIS
From the results of RFLP analysis the grandparen-
tal derivation of the patient's X chromosome could
be deduced in 22 of the 41 families (table 2). The X
chromosome of the patient was found to be derived
from the grandfather twice äs often äs from the
grandmother (GP-X/GM-X = 2). From fig l it fol-
lows that this finding corresponds with a minimum
value for ν/μ of 4.
COMBINED RESULTS OF RFLP ANALYSIS AND
COAGULATION ASSAYS
The most probable level of mutation for the grand-
paternally and grandmaternally derived X chromo-
somes is depicted in fig 4 and is based on the results
of coagulation assays in the mother and grand-
mother of the patient. Fourteen of the 15 mothers in
whom the at risk X chromosome was of paternal
origin had an LR-VIII above l, 13 even above 10, so
that in these cases the mutation most probably
occurred in the grandfather of the patient. However,
Table 2 Grandparental derivation of the X chromosome of
isolated haemophilia A patients by RFLP analysis
(n = 41).
RFLP
Grandparent Intragenic Extragenic Total
five of the seven mothers in whom the at risk X
chromosome was of maternal origin had an LR-VIII
below l, so that in these cases the mutation most
probably occurred in the mother of the patient. In
the remaining two cases the mother äs well äs the
grandmother of the patient had'an LR-VIII above l,
which indicates that the mutation had occurred in
the great grandparental or an even more remote
generation.
Fourteen of the 22 mothers included in this figure
are thus most probably carriers (LR-VIII > 1) by
new mutation. It is striking that, in all these women,
the mutation originated in the paternal X chromo-
some.
PROBABILITY OF CARRIERSHIP FOR MOTHERS OF AN
ISOLATED PATIENT
The theoretical probability of carriership for
mothers of an isolated patient was calculated to be
93% for a mutation ratio of 12-1 and 86% for a
mutation ratio of 5-2. In addition to carriers in the
classical sense, the first percentage may include
women who are mosaic for the mutation, whereas
the second percentage does not. In both analyses the
remaining percentages of mothers, 7% and 14%
Grandfather
Grandmother
Unknown
15
7
19
Figure 4 Most probable level of mutation for the
grandpaternally and grandmaternally derived X
chromosomes based on the results of coagulation assays in
the mother and grandmother of the patient. Solid arrows,
grandparental derivation by RFLP analysis; broken
arrovis, probable level ofmutation by RFLP analysis and
coagulation assays (LR-VIII >1 carrier, LR-VIII <1
non-carrier).
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respectively, are expected to be either non-carrier or
mosaic for the mutation.
Discussion
In this study, we have found evidence that haemo-
philia A mutations occur more frequently in males
than in females. Based on pedigree analysis and
coagulation assays in 41 families with an isolated
patient, the sex ratio of mutation frequencies (ν/μ)
was conservatively estimated to be 5-2 with a 95%
confidence interval of 1-8 to 15-1. The results of
RFLP analysis were in agreement with this estimate.
Most of the earlier studies indicated a higher
mutation frequency in males äs well,1026"31 though
some did not.32"35 The studies based on segregation
analysis1026273235 have been criticised for ascertain-
ment bias and the techniques used to correct for this.
Rosendaal et alw virtually eliminated the possibility
of selective ascertainment by using only Information
from pedigrees with an initially isolated patient. In
this study, a slight preponderance of the male muta-
tion frequency, in a ratio of 2:1, was found. In
addition to poor ascertainment, many of the studies
based on carrier detection tests2628"313334 have been
hampered by unreliable carrier detection methods or
an inadequate Interpretation of them. Winter et aPl
strictly controlled carrier detection tests and their
Interpretation according to the World Health Orga-
nization recommendation.36 Based on the results of
coagulation assays in 21 families with an isolated
patient, the sex ratio (ν/μ) was estimated to be 9-6
with a 95% confidence interval of 2-2 to 41-5.
Recently, a meta-analysis of six of these earlier
studies, in which an estimate of ν/μ was obtained,
confirmed a higher mutation frequency in males
(ν/μ: 3-1).'»
The method which we have developed according
to the model of Winter6 allows, in principle, inclu-
sion of all types of pedigrees, irrespective of the
number of affected males and of the generation(s) in
which they occur. By basing the likelihood for the
outcome of carrier detection tests on the pedigree
Information, that is, the number and genetic Status
of the male relatives, selection for a specific type of
pedigree does not affect the estimated value of the
Parameters. At present, in view of the possible
occurrence of mosaicism for mutations, we consider
it advisable to limit this type of analysis to pedigrees
with an isolated patient. Alternatively, when a cer-
tain value for ν/μ has been assumed, the method can
be used for individual probability calculations in
genetic counselling.
In this study, the estimate of ν/μ appeared to be
virtually independent of the prior probability of
carriership for the woman in the pedigree designated
the progenitor. In most of our pedigrees it con-
cerned the great grandmother of the patient. The
probability of carriership for the progenitor is deter-
mined by the mutation frequency in males and
females äs well äs by the reproductive fitness in
affected males. When more generations occur
between patient and progenitor, the impact of Ω on
the carrier Status of the mother of an isolated patient
and, hence, the sex ratio of mutation frequencies,
becomes less. As a consequence, the reproductive
fitness of affected males, whatever the value, cannot
be of major influence either.
When families with an isolated patient are ascer-
tained through female relatives of the patient, the
estimate of ν/μ may be flawed by the referral pattern
of these women. Since we are one of the major
centres for carrier detection of haemophilia in the
Netherlands, we cannot exclude the possibility that
relatively more complex cases, that is, women who
are difficult to classify, have been referred to us. In
that case our estimate of ν/μ would be too low.
We have estimated ν/μ based exclusively on the
results of coagulation assays in mothers and grand-
mothers of an isolated patient to avoid the possible
influence of germline mosaicism. There appeared to
be a considerable difference in the estimate based on
coagulation assays in all available female relatives,
12-1 versus 5-2. The actual finding of germline
mosaicism in one of the families included in this
study25 has proven that the estimate of 12-1 may
indeed be too high because of this phenomenon. The
impact of germline mosaicism in haemophilia is, äs
yet, unknown. Therefore, a more conservative ap-
proach to estimate ν/μ may be warranted.
To date, Information from DNA studies on the
origin of mutations is limited. Based on the results of
RFLP analysis and of coagulation assays in families
with an isolated patient, Bernardi et a/37 arrived at a
higher mutation frequency in males. It should be
noted, however, that the chance to define the origin
of the mutation by RFLP analysis depends on the
Information provided by the family and is easily
biased in favour of males. We have chosen an
approach by which limited, though unbiased, in-
formation from the RFLP studies, namely the
grandparental derivation of the patient's X chromo-
some, was used to estimate ν/μ. For that purpose, we
have defined the relationship between ν/μ and the
ratio of grandpaternally and grandmaternally de-
rived X chromosomes specifically for families with
an isolated patient. A minimum estimate of ν/μ
could thus be obtained. In addition, we have shown
that predominant inheritance of the grandmaternal
X chromosome does not exclude a higher mutation
frequency in males.
When the actual gene defect is known, the origin
of the mutation can be unequivocally shown. In 22
haemophilia A families, the origin of the mutation
has been reported.38"48 Although the figures are
small, they favour a higher mutation frequency in
. . .. ,.,.^.... .. , •-.';-.
ί
ΐ.:ξ;
678 Bröcker-Vriends, Rosendaal, van Houwelingen, Bakker, van Ommen, van de Kamp, Briet
males. In contrast, for another X linked recessive
disease, Duchenne muscular dystrophy (DMD),
segregation analysis and carrier detection tests äs
well äs recent molecular analysis have not provided
convincing evidence for a difference in mutation
frequency between males and females.4950 DMD is
caused by a deletion in the dystrophin gene in 60 to
65% of the cases,5152 whereas this applies to only 4 to
6% of the haemophilia A cases.4553 These figures
might indicate that there is a correlation between the
type of mutation and its male or female origin. The
findings for haemophilia A show that deletions
might be more frequently associated with somatic or
germline mosaicism than point mutations, which in
turn might be related to the possible mechanisms of
mutagenesis causing the respective mutations.
Recently, recurrence risks owing to mosaicism have
been reported for DMD.50 In view of a possible
relation between the type of mutation and the occur-
rence of mosaicism, caution is needed in applying
diese figures to haemophilia A families äs well.
Knowledge of the sex ratio of mutation frequen-
cies is important for genetic counselling in families
with an isolated haemophilia A patient. The higher
the ν/μ, the higher is the probability of carriership
for mothers of an isolated patient. The most conser-
vative estimate of ν/μ in the present study (5-2)
results in a probability of carriership of 86%.
Although this implies that 14% of the mothers are
not expected to be carriers in the classical sense,
these mothers are not exempted from transmission
of the same mutation to other children because of the
possibility of germline mosaicism.
As early äs 1935, Haldane3 not only postulated a
sex difference in mutation rates, but also hinted at
the possibility of mosaicism. The occurrence of
somatic and germline mosaicism has now been
definitely established by molecular analysis. The
prevalence of this phenomenon and related recur-
rence risks need to be evaluated further. In addition,
studies at the gene level may provide a definite
answer on a possible sex difference of mutation
frequencies, not only for all gene defects combined,
but also for the different types of mutation separ-
ately. International collaboration will be essential to
achieve this goal.
Finally, in view of current knowledge one cannot
but wonder: who is a 'truly sporadic case'?
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Appendix Estimation of the sex ratio of mutation
frequencies from carrier detection tests in an X linked
recessive disorder.
The subjects (D„) in each pedigree (S) are consecut-
ively denoted D, to Dnv for the females and Dnv^, to
D„ for the males. D, is the woman in the pedigree for
whom there is no previous Information, the progen-
itor. The mother of the respective subjects is
denoted M; (i = 2,.. ., n). Let LV be l if a subject,
male or female, carries the abnormal gene and let D;
be 0 if a subject does not carry the abnormal gene.
The probability for each subject in a pedigree to
carry the abnormal gene, given the genetic Status of
the mother, is:
For the progenitor:
Ρ(Ο, = 1) = Ω
For females by new mutation:
Θ2 i = 2,...,nv
For males by new mutation:
PCD, = 110^ = 0) = μ Θ3 i = nv+l,...,n
For males and females by inheritance:
^ = 1) = P(DS = OID^ = 1) = 1/2
The probability for the genetic Status of the subjects
belonging to a specific pedigree is then the product
of the individual probabilities
680 Bröcker- Vriends, Rosendaal, van Houwelingen, Bakker, van Ommen, van de Kamp, Briet
where F is the number of new female mutants, H is
the number of new male mutants, and C is the
number of children of carrier mothers. It should be
noted that this expression includes pedigrees in
which no mutation occurred (D, + F + H = 0) äs well
äs pedigrees in which a mutation occurred more than
once (D, + F + H>1).
If we restrict the possible type of pedigrees to
pedigrees with only one mutational event
(D, + F + H = 1), the probability for the subjects of a
specific pedigree becomes
P(D„ . . ., n) = (ϋ,Θ, + F02 + H03)(i)c.
Since the selection of the investigated pedigrees
from this population of pedigrees is unclear and
depends on the genetic Status of the males, we have
used the probability of carriership for the females
conditional on the genetic Status of the males.
Accordingly, the probability for the genetic Status of
the females in a specific pedigree is given by the
expression
Dp...,Dnv
and depends only on the ratio of Θ,, Θ2, and Θ3. If
one sets Θ3 at l, the probability depends on two
Parameters Θ,/Θ3 = δ, and Θ2/Θ3 = δ2, where 6, equals
Ω/μ and δ2 equals (μ + ν)/μ. The δ dependence of the
probability for the genetic Status of the females in a
specific pedigree can be denoted by
P6(D„...,DJDnv+1,...,D,,).
Let LR-VIII,. be the likelihood ratio carrier/non-
carrier based on the results of factor VIII assays for
the female subjects (i= l,.. .,nv). The probability
for the genetic Status of the fernales together with the
results of factor VIII assays, conditional on the
number and genetic Status of the males, is then
proportional to
P6(D„..., DJD„+1J...,D„)fl LR-VIII?·.
Hence, the likelihood for the results of factor VIII
assays in the females of a specific pedigree is given by
1V . .,DJD„+1, . . „Dj
D,, . , ., D
nv
D, + F+H=1
The likelihood for the results of factor VIII assays in
all the investigated pedigrees is expressed by
L(5) = Π ί Σ P6(D„ . . ., D„JDnv+ „ . . ., D„)f[ LR-VIII?·.
^ (
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